Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Heart Failure: Traditional Therapies and Novel Agents


This CPE activity is intended to refresh pharmacists on the current ACCF/AHA guideline recommendations on the use of pharmacotherapy in heart failure and to introduce them to two novel heart failure agents, sacubitril-valsartan and ivabridine.  The activity will describe the agents' characteristics and potential role in heart failure therapy.

Fee

$10.00

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Disclosure Policy
The disclosure policies of the SIUE School of Pharmacy Office of Continuing Professional Education requires all persons in a position to control content to disclose any relevant financial relationships with commercial interests. If a conflict is identified, the Office of Professional Continuing Education will initiate a process for resolving the conflict.  The existence of relationships does not necessarily imply bias or lessen the value of the activity.  All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
The persons required to disclose conflicts include all course faculty, the SIUE CPE administrator, all activity planners and all reviewers.  The relevant commercial financial relationships or affiliations must have occured over the past 12 months.

 
Accreditation Council for Pharmacy Education
Southern Illinois University Edwardsville School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  
 
 
 
The participant must provide the correct NABP ePID number/DOB combination in their electronic profile. All CPE evaluations must be completed within 60 days of activity. It is the participant's responsibility to check that their credit records are correct within the 60 day period after completion of the activity.   Log in to CPE Monitor at www.mycpemonitor.net to view a list of all ACPE-accredited activities you have taken. Any discrepancies must be resolved with the CPE Provider directly and in a timely manner.
 
 
 

 

Requirements for CE Credit

 
To receive CE credit, the participant must complete the entire course (be present for the entire live presentation, read the monograph in its entirety etc.), complete the online pretest and post-test with a score greater than that specified for the course.   The participant must  also complete the online evaluation.
 
 
Continuing pharmacy education credit is reported to CPE Monitor once the post-test & evaluation are successfully completed.  

Support/Credits

We would like to thank our mentor, Dr. Jingyan Fan-Hecht, PharmD, for her expertise and guidance on the subject matter of heart failure. We would also like to thank Dr. Walter Siganga, PhD, for the opportunity to publish this CE piece and his guidance throughout the process.

 

 

 

Objectives

  • Apply the current ACCF/AHA guideline recommendations for pharmacotherapy in heart failure.
  • Describe the mechanism of action of sacubitril-valsartan and identify common side effects.
  • Describe the mechanism of action of ivabradine and identify common side effects.
  • Propose a place in therapy for the novel heart failure agents.

Speaker(s)/Author(s)

Sarah Cook picture

Sarah Cook
SIUE School of Pharmacy


Brief Bio : Sarah Cook is a PharmD candidate at the SIUE School of Pharmacy who is pursuing the education specialization. She plans to complete a general PGY1 residency after graduation and possibly continue on to pursue a PGY2 residency in critical care or geriatrics.
Disclosure : Sarah Cook has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.
Tate Hohulin picture

Tate Hohulin
SIUE School of Pharmacy


Brief Bio : I am currently a PharmD Candidate attending SIUE School of pharmacy. I plan on pursuing a residency post-graduation.
Disclosure : Tate Hohulin has completed and submitted the SIUE School of Pharmacy Continuing Pharmacy Education Form for Disclosure of Potential Conflicts of Interest and none were reported.

Activity Number

0480-0000-15-006-H01-P

Release Date: Oct 12, 2015
Credit Expiration Date: Oct 12, 2018

CE Hours

1.00